Previous Article | Next Article 
Molecular and Cellular Biology, January 2003, p. 543-554, Vol. 23, No. 2
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.2.543-554.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
The Ras/Raf/MEK/Extracellular Signal-Regulated Kinase Pathway Induces Autocrine-Paracrine Growth Inhibition via the Leukemia Inhibitory Factor/JAK/STAT Pathway
Jong-In Park,1 Christopher J. Strock,1 Douglas W. Ball,1,2 and Barry D. Nelkin1*
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,1
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 212312
Received 9 July 2002/
Returned for modification 18 September 2002/
Accepted 22 October 2002
Sustained activation of the Ras/Raf/MEK/extracellular signal-regulated kinase (ERK) pathway can lead to cell cycle arrest in many cell types. We have found, with human medullary thyroid cancer (MTC) cells, that activated Ras or c-Raf-1 can induce growth arrest by producing and secreting an autocrine-paracrine factor. This protein was purified from cell culture medium conditioned by Raf-activated MTC cells and was identified by mass spectrometry as leukemia inhibitory factor (LIF). LIF expression upon Raf activation and subsequent activation of JAK-STAT3 was also observed in small cell lung carcinoma cells, suggesting that this autocrine-paracrine signaling may be a common response to Ras/Raf activation. LIF was sufficient to induce growth arrest and differentiation of MTC cells. This effect was mediated through the gp130/JAK/STAT3 pathway, since anti-gp130 blocking antibody or dominant-negative STAT3 blocked the effects of LIF. Thus, LIF expression provides a novel mechanism allowing Ras/Raf signaling to activate the JAK-STAT3 pathway. In addition to this cell-extrinsic growth inhibitory pathway, we find that the Ras/Raf/MEK/ERK pathway induces an intracellular growth inhibitory signal, independent of the LIF/JAK/STAT3 pathway. Therefore, activation of the Ras/Raf/MEK/ERK pathway can lead to growth arrest and differentiation via at least two different signaling pathways. This use of multiple pathways may be important for "fail-safe" induction and maintenance of cell cycle arrest.
* Corresponding author. Mailing address: Rm. 552, 1650 Orleans St., Baltimore, MD 21231. Phone: (410) 955-8506. Fax: (410) 614-9884. E-mail:
bnelkin{at}jhmi.edu.
Molecular and Cellular Biology, January 2003, p. 543-554, Vol. 23, No. 2
0022-538X/03/$08.00+0 DOI: 10.1128/MCB.23.2.543-554.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Romesser, P. B., Perlman, D. H., Faller, D. V., Costello, C. E., McComb, M. E., Denis, G. V.
(2009). Development of a Malignancy-Associated Proteomic Signature for Diffuse Large B-Cell Lymphoma. Am. J. Pathol.
175: 25-35
[Abstract]
[Full Text]
-
Kloos, R. T., Ringel, M. D., Knopp, M. V., Hall, N. C., King, M., Stevens, R., Liang, J., Wakely, P. E. Jr, Vasko, V. V., Saji, M., Rittenberry, J., Wei, L., Arbogast, D., Collamore, M., Wright, J. J., Grever, M., Shah, M. H.
(2009). Phase II Trial of Sorafenib in Metastatic Thyroid Cancer. JCO
27: 1675-1684
[Abstract]
[Full Text]
-
Kim, D.-I., Lee, S.-J., Lee, S.-B., Park, K., Kim, W.-J., Moon, S.-K.
(2008). Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression. Carcinogenesis
29: 1701-1709
[Abstract]
[Full Text]
-
Sippel, R. S., Kunnimalaiyaan, M., Chen, H.
(2008). Current Management of Medullary Thyroid Cancer. The Oncologist
13: 539-547
[Abstract]
[Full Text]
-
Hong, D., Ye, L., Gagel, R., Chintala, L., El Naggar, A. K., Wright, J., Kurzrock, R.
(2008). Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib. Molecular Cancer Therapeutics
7: 1001-1006
[Abstract]
[Full Text]
-
Kunnimalaiyaan, M., Chen, H.
(2007). Tumor Suppressor Role of Notch-1 Signaling in Neuroendocrine Tumors. The Oncologist
12: 535-542
[Abstract]
[Full Text]
-
Kunnimalaiyaan, M., Vaccaro, A. M., Ndiaye, M. A., Chen, H.
(2007). Inactivation of glycogen synthase kinase-3{beta}, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells. Molecular Cancer Therapeutics
6: 1151-1158
[Abstract]
[Full Text]
-
Lin, H., Chen, M.-C., Chiu, C.-Y., Song, Y.-M., Lin, S.-Y.
(2007). Cdk5 Regulates STAT3 Activation and Cell Proliferation in Medullary Thyroid Carcinoma Cells. J. Biol. Chem.
282: 2776-2784
[Abstract]
[Full Text]
-
Kunnimalaiyaan, M., Vaccaro, A. M., Ndiaye, M. A., Chen, H.
(2006). Overexpression of the NOTCH1 Intracellular Domain Inhibits Cell Proliferation and Alters the Neuroendocrine Phenotype of Medullary Thyroid Cancer Cells. J. Biol. Chem.
281: 39819-39830
[Abstract]
[Full Text]
-
Sangerman, J., Lee, M. S., Yao, X., Oteng, E., Hsiao, C.-H., Li, W., Zein, S., Ofori-Acquah, S. F., Pace, B. S.
(2006). Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves {gamma}-globin activation by CREB1 and ATF-2. Blood
108: 3590-3599
[Abstract]
[Full Text]
-
Han, C., Demetris, A. J., Stolz, D. B., Xu, L., Lim, K., Wu, T.
(2006). Modulation of Stat3 Activation by the Cytosolic Phospholipase A2{alpha} and Cyclooxygenase-2-controlled Prostaglandin E2 Signaling Pathway. J. Biol. Chem.
281: 24831-24846
[Abstract]
[Full Text]
-
Van Gompel, J. J., Kunnimalaiyaan, M., Holen, K., Chen, H.
(2005). ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells. Molecular Cancer Therapeutics
4: 910-917
[Abstract]
[Full Text]
-
Wollmann, W., Goodman, M. L., Bhat-Nakshatri, P., Kishimoto, H., Goulet, R. J. Jr, Mehrotra, S., Morimiya, A., Badve, S., Nakshatri, H.
(2005). The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells. Carcinogenesis
26: 900-907
[Abstract]
[Full Text]
-
Suzuki, M., Shiraha, H., Fujikawa, T., Takaoka, N., Ueda, N., Nakanishi, Y., Koike, K., Takaki, A., Shiratori, Y.
(2005). Des-{gamma}-carboxy Prothrombin Is a Potential Autologous Growth Factor for Hepatocellular Carcinoma. J. Biol. Chem.
280: 6409-6415
[Abstract]
[Full Text]
-
Kim, E.-J., Park, J.-I., Nelkin, B. D.
(2005). IFI16 Is an Essential Mediator of Growth Inhibition, but Not Differentiation, Induced by the Leukemia Inhibitory Factor/JAK/STAT Pathway in Medullary Thyroid Carcinoma Cells. J. Biol. Chem.
280: 4913-4920
[Abstract]
[Full Text]
-
Nozaki, I., Lunz, J. G. III, Specht, S., Park, J.-I., Giraud, A. S., Murase, N., Demetris, A. J.
(2004). Regulation and Function of Trefoil Factor Family 3 Expression in the Biliary Tree. Am. J. Pathol.
165: 1907-1920
[Abstract]
[Full Text]
-
Rhee, K. D., Goureau, O., Chen, S., Yang, X.-J.
(2004). Cytokine-Induced Activation of Signal Transducer and Activator of Transcription in Photoreceptor Precursors Regulates Rod Differentiation in the Developing Mouse Retina. J. Neurosci.
24: 9779-9788
[Abstract]
[Full Text]
-
Tai, C.-J., Chang, S.-J., Leung, P. C. K., Tzeng, C.-R.
(2004). Adenosine 5'-Triphosphate Activates Nuclear Translocation of Mitogen-Activated Protein Kinases Leading to the Induction of Early Growth Response 1 and Raf Expression in Human Granulosa-Luteal Cells. J. Clin. Endocrinol. Metab.
89: 5189-5195
[Abstract]
[Full Text]
-
Fernandez, S., Jose, P., Avdiushko, M. G., Kaplan, A. M., Cohen, D. A.
(2004). Inhibition of IL-10 Receptor Function in Alveolar Macrophages by Toll-Like Receptor Agonists. J. Immunol.
172: 2613-2620
[Abstract]
[Full Text]